DGAP-News: Genmab Announces Financial Results for the First Quarter 2012
Genmab A/S
15.05.2012 17:01
—————————————————————————
May 15, 2012; Copenhagen, Denmark;
Interim Report for the First Quarter 2012
— Arzerra(r) net sales increased 32% over Q1 2011
— New Drug Application for ofatumumab submitted in Japan
— Amended protocol for ofatumumab Phase III head to head study vs rituximab
in DLBCL; moved estimated primary data readout forward
— Improved operating result year on year due to lower opera
